Director/PDMR Shareholding

RNS Number : 9777N

Epistem Holdings plc

04 October 2012

 



Epistem Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 252 ordinary shares of 1.5p each. These shares were acquired on 7 August 2012, 31 August 2012 and 18 September 2012 at prices of 415p, 435p and 478p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                             9,781                                    0.11%

Dr Catherine Booth                   984,136                                  11.11%

Dr Jeffrey Moore                        16,461                                    0.18%

John Rylands                            194,034                                    2.19%

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel /Vijay Barathan                                                      [phone]

 

END

 

 

RDSBSBDGRSGBGDS